English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 84461/113095 (75%)
造訪人次 : 22177688      線上人數 : 755
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    政大機構典藏 > 理學院 > 資訊科學系 > 期刊論文 >  Item 140.119/75814
    請使用永久網址來引用或連結此文件: http://nccur.lib.nccu.edu.tw/handle/140.119/75814

    題名: A guideline-based decision support for pharmacological treatment can improve the quality of hyperlipidemia management
    作者: Chen, Kung
    貢獻者: 資科系
    關鍵詞: Clinical decision support systems;Clinical practice guidelines;Evidence-based medicine;Hyperlipidemia;Order entry;Order entry system;Artificial intelligence;Decision making;Decision theory;Hospital data processing;Decision support systems;hydroxymethylglutaryl coenzyme A reductase inhibitor;low density lipoprotein cholesterol;aged;algorithm;article;cholesterol blood level;clinical effectiveness;decision support system;female;health care quality;human;hyperlipidemia;major clinical study;male;performance measurement system;practice guideline;prescription;Decision Support Systems, Clinical;Guidelines as Topic;Humans;Hyperlipidemias;Quality of Health Care
    日期: 2010-03
    上傳時間: 2015-06-15 17:46:06 (UTC+8)
    摘要: Introduction: The Institute of Medicine has identified both Computerized Physician Order Entry (CPOE) and Electronic Prescription (EP) as key in reducing medication errors and improving safety. Many computerized clinical decision support systems (CDSSs) improve practitioner performance. However, the development of CDSSs involves a long cycle time that makes it difficult to apply in a wider scope. Methods: In this study, we integrated the hyperlipidemia treatment guideline ATP III (Adult Treatment Panel III) in a CPOE of a medical center. The first 200 consecutive patients followed up more than 1 year were recorded for analysis. Results: Our study revealed that 130 (65%) patients reached the LDL-C (low density lipoprotein-cholesterol) goal in 1 year. For those who with CDSS finished, 74% reached the LDL-C goal. For those who with CDSS exited, 57% reached the LDL-C goal. The odds ratio is 2.1 (1.2, 3.8) (p = 0.022), which means for those who with CDSS finished can have 2 times of chance to reach the LDL-C goal. The mean of days to attain the LDL-C goal level after initiation of antihyperlipidemia therapy was 175 ± 98 days. 11,806 prescribing records from 8023 patients were collected for analyzing the reasons of prematurely exiting the CDSS. The most frequent reason for exiting the system is "too busy to use". Conclusion: We conclude that a CPOE with CDSS integrated may let more hyperlipidemia patients reach the LDL-C goal. However, data also showed the total prescribing time may increase. The results of a preliminary evaluation are presented to illustrate that the CDSSs can improve the quality of hyperlipidemia management. © 2009 Elsevier Ireland Ltd. All rights reserved.
    關聯: Computer Methods and Programs in Biomedicine,Volume 97, Issue 3, Pages 280-285
    資料類型: article
    DOI 連結: http://dx.doi.org/10.1016/j.cmpb.2009.12.004
    DOI: 10.1016/j.cmpb.2009.12.004
    顯示於類別:[資訊科學系] 期刊論文


    檔案 描述 大小格式瀏覽次數
    1-s2.0-S0169260709003071-main.pdf612KbAdobe PDF840檢視/開啟


    社群 sharing

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋